Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
Lee, Michael S, Ryoo, Baek-Yeol, Hsu, Chih-Hung, Numata, Kazushi, Stein, Stacey, Verret, Wendy, Hack, Stephen P, Spahn, Jessica, Liu, Bo, Abdullah, Heba, Wang, Yulei, He, Aiwu Ruth, Lee, Kyung-Hun, Bang, Y-J, Bendell, J, Chao, Y, Chen, J-S, Chung, H C, Davis, S L, Dev, A, Gane, E, George, B, He, A R, Hochster, H, Hsu, C-H, Ikeda, M, Lee, J, Lee, M, Mahipal, A, Manji, G, Morimoto, M, Numata, K, Pishvaian, M, Qin, S, Ryan, D, Ryoo, B-Y, Sasahira, N, Stein, S, Strickler, J, Tebbutt, N
Published in The lancet oncology (01.06.2020)
Published in The lancet oncology (01.06.2020)
Get full text
Journal Article
A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy
Bodoky, György, Timcheva, Constanta, Spigel, David Robert, La Stella, Phillip Joseph, Ciuleanu, Tudor Eliade, Pover, G., Tebbutt, N. C.
Published in Investigational new drugs (01.06.2012)
Published in Investigational new drugs (01.06.2012)
Get full text
Journal Article
The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial
Mooi, J.K., Wirapati, P., Asher, R., Lee, C.K., Savas, P., Price, T.J., Townsend, A., Hardingham, J., Buchanan, D., Williams, D., Tejpar, S., Mariadason, J.M., Tebbutt, N.C.
Published in Annals of oncology (01.11.2018)
Published in Annals of oncology (01.11.2018)
Get full text
Journal Article
Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17
Brulé, S.Y, Jonker, D.J, Karapetis, C.S, O’Callaghan, C.J, Moore, M.J, Wong, R, Tebbutt, N.C, Underhill, Cr, Yip, D, Zalcberg, J.R, Tu, D, Goodwin, R.A
Published in European journal of cancer (1990) (01.07.2015)
Published in European journal of cancer (1990) (01.07.2015)
Get full text
Journal Article
Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer
Lee, B., Lipton, L., Cohen, J., Tie, J., Javed, A.A., Li, L., Goldstein, D., Burge, M., Cooray, P., Nagrial, A., Tebbutt, N.C., Thomson, B., Nikfarjam, M., Harris, M., Haydon, A., Lawrence, B., Tai, D.W.M., Simons, K., Lennon, A.M., Wolfgang, C.L., Tomasetti, C., Papadopoulos, N., Kinzler, K.W., Vogelstein, B., Gibbs, P.
Published in Annals of oncology (01.09.2019)
Published in Annals of oncology (01.09.2019)
Get full text
Journal Article
Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C
Price, T.J., Zannino, D., Wilson, K., Simes, R.J., Cassidy, J., Van Hazel, G.A., Robinson, B.A., Broad, A., Ganju, V., Ackland, S.P., Tebbutt, N.C.
Published in Annals of oncology (01.06.2012)
Published in Annals of oncology (01.06.2012)
Get full text
Journal Article
Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial
TEBBUTT, N. C, CUMMINS, M. M, SOURJINA, T, STRICKLAND, A, VAN HAZEL, G, GANJU, V, GIBBS, D, STOCKLER, M, GEBSKI, V, ZALCBERG, J
Published in British journal of cancer (02.02.2010)
Published in British journal of cancer (02.02.2010)
Get full text
Journal Article
A randomised, double-blind, placebo-controlled phase 2 study of trebananib (AMG 386) in combination with FOLFIRI in patients with previously treated metastatic colorectal carcinoma
PEETERS, M, STRICKLAND, A. H, JAIN, R, TEBBUTT, N. C, LICHINITSER, M, SURESH, A. V. S, MANIKHAS, G, SHAPIRO, J, ROGOWSKI, W, HUANG, X, WU, B, WARNER, D
Published in British journal of cancer (19.02.2013)
Published in British journal of cancer (19.02.2013)
Get full text
Journal Article
Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer
Weickhardt, A J, Williams, D S, Lee, C K, Chionh, F, Simes, J, Murone, C, Wilson, K, Parry, M M, Asadi, K, Scott, A M, Punt, C J A, Nagtegaal, I D, Price, T J, Mariadason, J M, Tebbutt, N C
Published in British journal of cancer (30.06.2015)
Published in British journal of cancer (30.06.2015)
Get full text
Journal Article
Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer
JONKER, D. J, KARAPETIS, C. S, SHAPIRO, J, SIU, L. L, WONG, R. P. W, BJARNASON, G, MOORE, M. J, ZALCBERG, J. R, KHAMBATA-FORD, S, HARBISON, C, O'CALLAGHAN, C. J, TU, D, SIMES, R. J, MALONE, D. P, LANGER, C, TEBBUTT, N, PRICE, T. J
Published in British journal of cancer (04.02.2014)
Published in British journal of cancer (04.02.2014)
Get full text
Journal Article
Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer
Eatock, M.M., Tebbutt, N.C., Bampton, C.L., Strickland, A.H., Valladares-Ayerbes, M., Swieboda-Sadlej, A., Van Cutsem, E., Nanayakkara, N., Sun, Y.-N., Zhong, Z.D., Bass, M.B., Adewoye, A.H., Bodoky, G.
Published in Annals of oncology (01.03.2013)
Published in Annals of oncology (01.03.2013)
Get full text
Journal Article
Efficacy and safety results from IMblaze370, a randomised Phase III study comparing atezolizumab+cobimetinib and atezolizumab monotherapy vs regorafenib in chemotherapy-refractory metastatic colorectal cancer
Bendell, J., Ciardiello, F., Tabernero, J., Tebbutt, N., Eng, C., Di Bartolomeo, M., Falcone, A., Fakih, M., Kozloff, M., Segal, N., Sobrero, A., Shi, Y., Roberts, L., Yan, Y., Chang, I., Uyei, A., Kim, T.
Published in Annals of oncology (01.06.2018)
Published in Annals of oncology (01.06.2018)
Get full text
Journal Article
Prevalence of hypoxia and correlation with glycolytic metabolism and angiogenic biomarkers in metastatic colorectal carcinoma
Lee, ST, Muralidharan, V., Tebbutt, N., Wong, P., Fang, C., Liu, Z., Gan, H., Sachinidis, J., Pathmaraj, K., Christophi, C., Scott, A. M.
Published in European journal of nuclear medicine and molecular imaging (01.05.2021)
Published in European journal of nuclear medicine and molecular imaging (01.05.2021)
Get full text
Journal Article
Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines
Ransom, D., Wilson, K., Fournier, M., Simes, R.J., Gebski, V., Yip, D., Tebbutt, N., Karapetis, C.S., Ferry, D., Gordon, S., Price, T.J.
Published in Annals of oncology (01.01.2014)
Published in Annals of oncology (01.01.2014)
Get full text
Journal Article
Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases
Tebbutt, N C, Norman, A R, Cunningham, D, Hill, M E, Tait, D, Oates, J, Livingston, S, Andreyev, J
Published in Gut (01.04.2003)
Published in Gut (01.04.2003)
Get full text
Journal Article
Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer
Elander, N O, Aughton, K, Ghaneh, P, Neoptolemos, J P, Palmer, D H, Cox, T F, Campbell, F, Costello, E, Halloran, C M, Mackey, J R, Scarfe, A G, Valle, J W, McDonald, A C, Carter, R, Tebbutt, N C, Goldstein, D, Shannon, J, Dervenis, C, Glimelius, B, Deakin, M, Charnley, R M, Anthoney, Alan, Lerch, M M, Mayerle, J, Oláh, A, Büchler, M W, Greenhalf, W
Published in British journal of cancer (01.04.2018)
Published in British journal of cancer (01.04.2018)
Get full text
Journal Article
Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer
Schofield, Penelope E., Stockler, M. R., Zannino, D., Tebbutt, N. C., Price, T. J., Simes, R. J., Wong, N., Pavlakis, N., Ransom, D., Moylan, E., Underhill, C., Wyld, D., Burns, I., Ward, R., Wilcken, N., Jefford, M.
Published in Supportive care in cancer (01.01.2016)
Published in Supportive care in cancer (01.01.2016)
Get full text
Journal Article
Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer
Price, T J, Bruhn, M A, Lee, C K, Hardingham, J E, Townsend, A R, Mann, K P, Simes, J, Weickhardt, A, Wrin, J W, Wilson, K, Gebski, V, Van Hazel, G, Robinson, B, Cunningham, D, Tebbutt, N C
Published in British journal of cancer (17.03.2015)
Published in British journal of cancer (17.03.2015)
Get full text
Journal Article
Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab
Tebbutt, N.C., Murphy, F., Zannino, D., Wilson, K., Cummins, M.M., Abdi, E., Strickland, A.H., Lowenthal, R.M., Marx, G., Karapetis, C., Shannon, J., Goldstein, D., Nayagam, S.S., Blum, R., Chantrill, L., Simes, R.J., Price, T.J.
Published in Annals of oncology (01.08.2011)
Published in Annals of oncology (01.08.2011)
Get full text
Journal Article